The independent source for health policy research, polling, and news.
15,641 - 15,660 of 112,572 Results
The British covid variant does not cause more severe disease in hospitalized patients, according to a new study. However, another study says the South African variant may be able to evade the Pfizer vaccine.
A dramatic increase in covid cases in Michigan caused Biden administration officials to warn that the state should "shut things down" as no corresponding vaccine supply boost will happen -- only more therapeutic drugs.
As the Food and Drug Administration investigates very rare reports of blood clots in six people who had the Johnson & Johnson covid-19 vaccine, federal health agencies are recommending that states halt its usage. More than 7 million doses of the vaccine have been administered.
As still more colleges join the list of those mandating covid vaccinations before fall, a study among current students examines the longer-term impact of vaccines on covid spread. Other looming vaccine requirements are also in the news.
More states open vaccine eligibility for adults over 16, bringing the country closer to the point in which almost anyone can sign up for the vaccine. Reports single out New Mexico and Alaska's Native American health providers as being particularly effective at delivering vaccines.
Today's early morning highlights from the major news organizations.
Opinion writers analyze covid and vaccine issues.
Global health news is reported out of China, Austria, Germany, the United Kingdom, Brazil, Israel and Bhutan.
A hospital chain and a nurse staffing firm sue each other over the cost of nurses during the pandemic. In other health care industry news, 3M sues a company, alleging it made fake N95 masks.
The Department of Agriculture issued an alert about ground turkey made by Plainville Brands. In other news, your newly discovered gray hair could be pandemic-related.
The 5-4 vote bars the state from enforcing a rule that limits both religious and non-religious gatherings in homes to no more than three households. Other news is from Massachusetts, Wisconsin, Florida, Maine, West Virginia and Ohio.
The chairman of the Federal Reserve warned that reopening the economy too quickly could lead to more covid cases that will in turn hurt the economy. "We will reopen too quickly, people will too quickly return to their old practices, and we’ll see another spike in cases.”
Google is exploring how patients may want to manage their own medical record data with a new tool, and Microsoft is ready to spend billions of dollars to buy an AI firm that could help doctors with note-taking and help predict patient needs.
A clinical trial says a treatment using "natural killer cells" is effective against Hodgkin lymphoma. Separately, retevmo, a drug from Eli Lilly already approved for lung and thyroid cancer treatments, has shown promise in beating rare tumors found elsewhere.
The president proposed the creation of a medical research agency to cure cancer, Alzheimer's and diabetes. He also wants $400 billion for long-term care of aged Americans.
California says half of its adults have been vaccinated, while Wisconsin says it hit 25%. More women are getting shots than men, but that statistic may be biased by the earliest group to get shots: health care workers. And the Texas governor uses bad math to claim herd immunity.
The vaccine maker revealed a week ago that its vaccine was effective in a late-stage trial in younger teens between 12 and 15. In other vaccine news, more colleges will mandate vaccines before the fall, and worries emerge that covid variants will upset school reopenings.
The latest figures shows that almost 40% of Marines have declined to be vaccinated for covid-19. Some have called on President Joe Biden to mandate the shot for members of the U.S. military.
So far, the Biden administration has said that it will not allocate additional supply to hot spots while Gov. Gretchen Whitmer continues to make her case. Federal officials said it would deploy other aid to increase testing.
The drugmaker says a single shot of its monoclonal antibody treatment reduced the chances of developing covid after exposure to the virus by 81%, which suggests it could be effective as a preventive. Regeneron is now seeking FDA approval for this.
© 2026 KFF